Serosurvey of anti‐rubella and anti‐measles IgG antibodies in young females in Jahrom, southern west Iran in 2012: A review of literature of the serological profile in Iran
Background Rubella and measles are two highly contagious viral childhood diseases. However, the high possibility of brutal effects of both microorganisms during pregnancy has kept them emerging as a major public health issue. The current study aimed to investigate the seroprevalence of rubella and m...
        Saved in:
      
    
          | Published in | Journal of general and family medicine Vol. 25; no. 2; pp. 95 - 101 | 
|---|---|
| Main Authors | , , , | 
| Format | Journal Article | 
| Language | English | 
| Published | 
        Japan
          John Wiley & Sons, Inc
    
        01.03.2024
     John Wiley and Sons Inc Wiley  | 
| Subjects | |
| Online Access | Get full text | 
| ISSN | 2189-7948 2189-6577 2189-7948  | 
| DOI | 10.1002/jgf2.677 | 
Cover
| Abstract | Background
Rubella and measles are two highly contagious viral childhood diseases. However, the high possibility of brutal effects of both microorganisms during pregnancy has kept them emerging as a major public health issue. The current study aimed to investigate the seroprevalence of rubella and measles among 15–25‐year‐old females in southwest Iran.
Method
This descriptive study was performed in Jahrom, southern west Iran during 2012. Serum samples from female individuals with an age of 15–25 years visiting main laboratories in our study location were collected and evaluated by a commercial ELISA kit for anti‐rubella and measles IgG antibodies.
Results
Among the 179 participants, regarding anti‐rubella antibodies, 171 (95.0%) were positive, 3 (1.7%) were negative, and 6 (3.3%) were borderline. Regarding anti‐measles antibodies, 166 (92.2%) of the subjects were positive, 1 (5.6%) was negative, and 13 (17.2%) were borderline. By assuming a positive value for the borderline cases, the ultimate findings demonstrated that 98.3% and 99.4% of the participants were immune against rubella and measles, respectively. There was no statistically significant association between measles and rubella immunity with age or the use of immunosuppressor medication.
Conclusion
Implementation of vaccine program has obtained significant immunity level in inhabitants, particularly women of childbearing age who play a more important role in herd immunity. Therefore, maintaining the national immune screening against rubella and measles is needed to take into consideration to maintain the current satisfactory level of immunization. | 
    
|---|---|
| AbstractList | Rubella and measles are two highly contagious viral childhood diseases. However, the high possibility of brutal effects of both microorganisms during pregnancy has kept them emerging as a major public health issue. The current study aimed to investigate the seroprevalence of rubella and measles among 15-25-year-old females in southwest Iran.BackgroundRubella and measles are two highly contagious viral childhood diseases. However, the high possibility of brutal effects of both microorganisms during pregnancy has kept them emerging as a major public health issue. The current study aimed to investigate the seroprevalence of rubella and measles among 15-25-year-old females in southwest Iran.This descriptive study was performed in Jahrom, southern west Iran during 2012. Serum samples from female individuals with an age of 15-25 years visiting main laboratories in our study location were collected and evaluated by a commercial ELISA kit for anti-rubella and measles IgG antibodies.MethodThis descriptive study was performed in Jahrom, southern west Iran during 2012. Serum samples from female individuals with an age of 15-25 years visiting main laboratories in our study location were collected and evaluated by a commercial ELISA kit for anti-rubella and measles IgG antibodies.Among the 179 participants, regarding anti-rubella antibodies, 171 (95.0%) were positive, 3 (1.7%) were negative, and 6 (3.3%) were borderline. Regarding anti-measles antibodies, 166 (92.2%) of the subjects were positive, 1 (5.6%) was negative, and 13 (17.2%) were borderline. By assuming a positive value for the borderline cases, the ultimate findings demonstrated that 98.3% and 99.4% of the participants were immune against rubella and measles, respectively. There was no statistically significant association between measles and rubella immunity with age or the use of immunosuppressor medication.ResultsAmong the 179 participants, regarding anti-rubella antibodies, 171 (95.0%) were positive, 3 (1.7%) were negative, and 6 (3.3%) were borderline. Regarding anti-measles antibodies, 166 (92.2%) of the subjects were positive, 1 (5.6%) was negative, and 13 (17.2%) were borderline. By assuming a positive value for the borderline cases, the ultimate findings demonstrated that 98.3% and 99.4% of the participants were immune against rubella and measles, respectively. There was no statistically significant association between measles and rubella immunity with age or the use of immunosuppressor medication.Implementation of vaccine program has obtained significant immunity level in inhabitants, particularly women of childbearing age who play a more important role in herd immunity. Therefore, maintaining the national immune screening against rubella and measles is needed to take into consideration to maintain the current satisfactory level of immunization.ConclusionImplementation of vaccine program has obtained significant immunity level in inhabitants, particularly women of childbearing age who play a more important role in herd immunity. Therefore, maintaining the national immune screening against rubella and measles is needed to take into consideration to maintain the current satisfactory level of immunization. Abstract Background Rubella and measles are two highly contagious viral childhood diseases. However, the high possibility of brutal effects of both microorganisms during pregnancy has kept them emerging as a major public health issue. The current study aimed to investigate the seroprevalence of rubella and measles among 15–25‐year‐old females in southwest Iran. Method This descriptive study was performed in Jahrom, southern west Iran during 2012. Serum samples from female individuals with an age of 15–25 years visiting main laboratories in our study location were collected and evaluated by a commercial ELISA kit for anti‐rubella and measles IgG antibodies. Results Among the 179 participants, regarding anti‐rubella antibodies, 171 (95.0%) were positive, 3 (1.7%) were negative, and 6 (3.3%) were borderline. Regarding anti‐measles antibodies, 166 (92.2%) of the subjects were positive, 1 (5.6%) was negative, and 13 (17.2%) were borderline. By assuming a positive value for the borderline cases, the ultimate findings demonstrated that 98.3% and 99.4% of the participants were immune against rubella and measles, respectively. There was no statistically significant association between measles and rubella immunity with age or the use of immunosuppressor medication. Conclusion Implementation of vaccine program has obtained significant immunity level in inhabitants, particularly women of childbearing age who play a more important role in herd immunity. Therefore, maintaining the national immune screening against rubella and measles is needed to take into consideration to maintain the current satisfactory level of immunization. Background Rubella and measles are two highly contagious viral childhood diseases. However, the high possibility of brutal effects of both microorganisms during pregnancy has kept them emerging as a major public health issue. The current study aimed to investigate the seroprevalence of rubella and measles among 15–25‐year‐old females in southwest Iran. Method This descriptive study was performed in Jahrom, southern west Iran during 2012. Serum samples from female individuals with an age of 15–25 years visiting main laboratories in our study location were collected and evaluated by a commercial ELISA kit for anti‐rubella and measles IgG antibodies. Results Among the 179 participants, regarding anti‐rubella antibodies, 171 (95.0%) were positive, 3 (1.7%) were negative, and 6 (3.3%) were borderline. Regarding anti‐measles antibodies, 166 (92.2%) of the subjects were positive, 1 (5.6%) was negative, and 13 (17.2%) were borderline. By assuming a positive value for the borderline cases, the ultimate findings demonstrated that 98.3% and 99.4% of the participants were immune against rubella and measles, respectively. There was no statistically significant association between measles and rubella immunity with age or the use of immunosuppressor medication. Conclusion Implementation of vaccine program has obtained significant immunity level in inhabitants, particularly women of childbearing age who play a more important role in herd immunity. Therefore, maintaining the national immune screening against rubella and measles is needed to take into consideration to maintain the current satisfactory level of immunization. BackgroundRubella and measles are two highly contagious viral childhood diseases. However, the high possibility of brutal effects of both microorganisms during pregnancy has kept them emerging as a major public health issue. The current study aimed to investigate the seroprevalence of rubella and measles among 15–25-year-old females in southwest Iran.MethodThis descriptive study was performed in Jahrom, southern west Iran during 2012. Serum samples from female individuals with an age of 15–25 years visiting main laboratories in our study location were collected and evaluated by a commercial ELISA kit for anti-rubella and measles IgG antibodies.ResultsAmong the 179 participants, regarding anti-rubella antibodies, 171 (95.0%) were positive, 3 (1.7%) were negative, and 6 (3.3%) were borderline. Regarding anti-measles antibodies, 166 (92.2%) of the subjects were positive, 1 (5.6%) was negative, and 13 (17.2%) were borderline. By assuming a positive value for the borderline cases, the ultimate findings demonstrated that 98.3% and 99.4% of the participants were immune against rubella and measles, respectively. There was no statistically significant association between measles and rubella immunity with age or the use of immunosuppressor medication.ConclusionImplementation of vaccine program has obtained significant immunity level in inhabitants, particularly women of childbearing age who play a more important role in herd immunity. Therefore, maintaining the national immune screening against rubella and measles is needed to take into consideration to maintain the current satisfactory level of immunization. Rubella and measles are two highly contagious viral childhood diseases. However, the high possibility of brutal effects of both microorganisms during pregnancy has kept them emerging as a major public health issue. The current study aimed to investigate the seroprevalence of rubella and measles among 15-25-year-old females in southwest Iran. This descriptive study was performed in Jahrom, southern west Iran during 2012. Serum samples from female individuals with an age of 15-25 years visiting main laboratories in our study location were collected and evaluated by a commercial ELISA kit for anti-rubella and measles IgG antibodies. Among the 179 participants, regarding anti-rubella antibodies, 171 (95.0%) were positive, 3 (1.7%) were negative, and 6 (3.3%) were borderline. Regarding anti-measles antibodies, 166 (92.2%) of the subjects were positive, 1 (5.6%) was negative, and 13 (17.2%) were borderline. By assuming a positive value for the borderline cases, the ultimate findings demonstrated that 98.3% and 99.4% of the participants were immune against rubella and measles, respectively. There was no statistically significant association between measles and rubella immunity with age or the use of immunosuppressor medication. Implementation of vaccine program has obtained significant immunity level in inhabitants, particularly women of childbearing age who play a more important role in herd immunity. Therefore, maintaining the national immune screening against rubella and measles is needed to take into consideration to maintain the current satisfactory level of immunization.  | 
    
| Author | Forouzani, Fatemeh Shahriarirad, Reza Mohammadi, Zahra Mojarad, Najmeh  | 
    
| AuthorAffiliation | 2 School of Medicine Yasuj University of Medical Sciences Yasuj Iran 4 Thoracic and Vascular Surgery Research Center Shiraz University of Medical Science Shiraz Iran 3 Student Research Committee Shiraz University of Medical Sciences Shiraz Iran 1 School of Medicine Jahrom University of Medical Sciences Jahrom Iran  | 
    
| AuthorAffiliation_xml | – name: 3 Student Research Committee Shiraz University of Medical Sciences Shiraz Iran – name: 1 School of Medicine Jahrom University of Medical Sciences Jahrom Iran – name: 2 School of Medicine Yasuj University of Medical Sciences Yasuj Iran – name: 4 Thoracic and Vascular Surgery Research Center Shiraz University of Medical Science Shiraz Iran  | 
    
| Author_xml | – sequence: 1 givenname: Najmeh surname: Mojarad fullname: Mojarad, Najmeh organization: Jahrom University of Medical Sciences – sequence: 2 givenname: Fatemeh surname: Forouzani fullname: Forouzani, Fatemeh organization: Yasuj University of Medical Sciences – sequence: 3 givenname: Zahra orcidid: 0000-0001-8841-6059 surname: Mohammadi fullname: Mohammadi, Zahra email: Z_mohammadi@icloud.com organization: Shiraz University of Medical Sciences – sequence: 4 givenname: Reza orcidid: 0000-0001-5454-495X surname: Shahriarirad fullname: Shahriarirad, Reza email: r.shahriari1995@gmail.com organization: Shiraz University of Medical Science  | 
    
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38481743$$D View this record in MEDLINE/PubMed | 
    
| BookMark | eNp9ksFu1DAQhiNUREupxBMgS1xAYovtJLbDBVUVXbaqxAE4W44zyXrl2Iud7GpvPAKPwjPxJDjdtrRIcLJn_Pn3eP55mh047yDLnhN8SjCmb1ddS08Z54-yI0pENeNVIQ7u7Q-zkxhXGGPCaY4pe5Id5qIQhBf5UfbzMwQfx7CBHfItUm4wv77_CGMN1qoUNrepHlS0ENGim1-nat-YFBqHdn50HWqhV3afuFTL4Ps3KPpxWEJwaAtxQIug3HRKMaHv0BkKsDGwnR61ZoCghjHAFKUrKKairO-MVhatg2-NhenqJPEse9wqG-HkZj3Ovl58-HL-cXb1ab44P7ua6bLkfEZrTOqCUSYYLxpMSsq4JopQreqcY82aRmAteCWg1bpRkFMGtOJa1DlhqsiPs8Vet_FqJdfB9CrspFdGXid86KQKg9EWZN4yVmLGFK-bQlVa4CJXWGNaCFwqgKT1eq81urXabZW1d4IEy8lEOZkok4mJfb9n12PdQ6PBDUHZBwU8PHFmKTu_STIV5VXOksKrG4Xgv42p9bI3UU9-OvBjlLQqOWGlKPOEvvwLXfkxuNTXiSpxVTJBE_Xifkl3tdxO0Z8XdZqlGKD93_dme3SbPN39k5OX8ws68b8BuXPo5w | 
    
| Cites_doi | 10.1186/s12985-020-01384-0 10.1136/bmjopen-2019-030873 10.26719/emhj.21.059 10.1093/tropej/fmq102 10.2471/BLT.07.041129 10.1080/21645515.2018.1436920 10.1089/vim.2017.0012 10.1080/21645515.2018.1504527 10.1371/journal.pone.0055043 10.3390/ijms21124435 10.1093/infdis/jir076 10.1016/j.vaccine.2019.10.026 10.1016/j.ijid.2021.06.016 10.1186/s12879-021-05970-7 10.1016/j.ajic.2012.04.327 10.1093/infdis/jir356 10.1186/s12865-021-00465-1 10.1016/j.jgyn.2012.01.008 10.26719/2004.10.4-5.468 10.1053/jhin.1999.0568 10.1016/j.vaccine.2017.04.044 10.1186/s12889-017-4077-2 10.1007/s10620-018-5321-z 10.1111/1469-0691.12469 10.1080/21645515.2019.1621146 10.1016/j.vaccine.2018.11.013 10.4103/ijpvm.IJPVM_334_20 10.1089/vim.2023.0026 10.1097/INF.0000000000001703 10.1016/j.ijid.2007.03.013 10.1086/421018 10.34172/jrhs.2020.05 10.21101/cejph.a4010  | 
    
| ContentType | Journal Article | 
    
| Copyright | 2024 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japan Primary Care Association. 2024 The Authors. Journal of General and Family Medicine published by John Wiley & Sons Australia, Ltd on behalf of Japan Primary Care Association. 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.  | 
    
| Copyright_xml | – notice: 2024 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japan Primary Care Association. – notice: 2024 The Authors. Journal of General and Family Medicine published by John Wiley & Sons Australia, Ltd on behalf of Japan Primary Care Association. – notice: 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.  | 
    
| DBID | 24P AAYXX CITATION NPM 7X7 7XB 8FI ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM ADTOC UNPAY DOA  | 
    
| DOI | 10.1002/jgf2.677 | 
    
| DatabaseName | Wiley Online Library Open Access CrossRef PubMed Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Health Research Premium Collection ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall DOAJ Directory of Open Access Journals  | 
    
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection ProQuest One Health & Nursing ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest One Academic UKI Edition ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) MEDLINE - Academic  | 
    
| DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database PubMed  | 
    
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository – sequence: 5 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database  | 
    
| DeliveryMethod | fulltext_linktorsrc | 
    
| Discipline | Medicine | 
    
| DocumentTitleAlternate | Mojarad et al | 
    
| EISSN | 2189-7948 | 
    
| EndPage | 101 | 
    
| ExternalDocumentID | oai_doaj_org_article_3f665066a7bd4a9c8043a0c024805aee 10.1002/jgf2.677 PMC10927936 38481743 10_1002_jgf2_677 JGF2677  | 
    
| Genre | researchArticle Journal Article  | 
    
| GeographicLocations | Iran Spain  | 
    
| GeographicLocations_xml | – name: Iran – name: Spain  | 
    
| GroupedDBID | 0R~ 1OC 24P 7X7 8FI AAHHS ACCFJ ACCMX ACXQS ADBBV ADKYN ADPDF ADZMN AEEZP AEQDE AFKRA AIWBW AJBDE ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN AOIJS AVUZU BCNDV BENPR BPHCQ BVXVI CCPQU EBS EJD EMOBN FYUFA GROUPED_DOAJ HMCUK HYE IAO IHR INH ITC JSF JSH KQ8 M~E OK1 OVD PIMPY PQQKQ PROAC RJT RPM RZJ TEORI UKHRP WIN AAMMB AAYXX AEFGJ AGXDD AIDQK AIDYY CITATION PHGZM PHGZT PUEGO NPM 7XB ABUWG AZQEC DWQXO PJZUB PKEHL PPXIY PQEST PQUKI 7X8 5PM ADTOC UNPAY  | 
    
| ID | FETCH-LOGICAL-c5577-2b01b46268674d015267c1a12cab370c6dd80c8798efccdae326e297c8b316a43 | 
    
| IEDL.DBID | DOA | 
    
| ISSN | 2189-7948 2189-6577  | 
    
| IngestDate | Tue Oct 14 19:08:42 EDT 2025 Sun Oct 26 03:28:44 EDT 2025 Tue Sep 30 17:10:00 EDT 2025 Fri Sep 05 13:55:53 EDT 2025 Tue Oct 07 06:48:24 EDT 2025 Wed Feb 19 02:05:34 EST 2025 Wed Oct 01 02:08:01 EDT 2025 Wed Jan 22 16:14:15 EST 2025  | 
    
| IsDoiOpenAccess | true | 
    
| IsOpenAccess | true | 
    
| IsPeerReviewed | true | 
    
| IsScholarly | true | 
    
| Issue | 2 | 
    
| Keywords | rubella antibody immunization programs measles vaccination  | 
    
| Language | English | 
    
| License | Attribution 2024 The Authors. Journal of General and Family Medicine published by John Wiley & Sons Australia, Ltd on behalf of Japan Primary Care Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. cc-by  | 
    
| LinkModel | DirectLink | 
    
| MergedId | FETCHMERGED-LOGICAL-c5577-2b01b46268674d015267c1a12cab370c6dd80c8798efccdae326e297c8b316a43 | 
    
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23  | 
    
| ORCID | 0000-0001-8841-6059 0000-0001-5454-495X  | 
    
| OpenAccessLink | https://doaj.org/article/3f665066a7bd4a9c8043a0c024805aee | 
    
| PMID | 38481743 | 
    
| PQID | 2955095682 | 
    
| PQPubID | 4370304 | 
    
| PageCount | 7 | 
    
| ParticipantIDs | doaj_primary_oai_doaj_org_article_3f665066a7bd4a9c8043a0c024805aee unpaywall_primary_10_1002_jgf2_677 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10927936 proquest_miscellaneous_2957165853 proquest_journals_2955095682 pubmed_primary_38481743 crossref_primary_10_1002_jgf2_677 wiley_primary_10_1002_jgf2_677_JGF2677  | 
    
| ProviderPackageCode | CITATION AAYXX  | 
    
| PublicationCentury | 2000 | 
    
| PublicationDate | March 2024 | 
    
| PublicationDateYYYYMMDD | 2024-03-01 | 
    
| PublicationDate_xml | – month: 03 year: 2024 text: March 2024  | 
    
| PublicationDecade | 2020 | 
    
| PublicationPlace | Japan | 
    
| PublicationPlace_xml | – name: Japan – name: Tokyo – name: Hoboken  | 
    
| PublicationTitle | Journal of general and family medicine | 
    
| PublicationTitleAlternate | J Gen Fam Med | 
    
| PublicationYear | 2024 | 
    
| Publisher | John Wiley & Sons, Inc John Wiley and Sons Inc Wiley  | 
    
| Publisher_xml | – name: John Wiley & Sons, Inc – name: John Wiley and Sons Inc – name: Wiley  | 
    
| References | 2021; 21 2023; 36 2020; 20 2017; 48 2019; 1 2022; 51 2021; 108 2019; 15 2013; 41 2022; 23 2020; 17 2002; 2 2020; 38 2008; 12 2000; 2 2011; 57 1999; 42 2003 2020; 10 2013; 8 2022; 28 2014; 22 2014; 43 2018; 24 2014; 20 2011; 204 2004; 10 2017; 30 2013; 16 2019; 64 2017; 17 2004; 38 2017; 35 2022; 13 2020; 21 2008; 86 2018; 37 2012; 41 2018; 14 2018; 36 Stegmann BJ (e_1_2_11_6_1) 2002; 2 Khazaei M (e_1_2_11_13_1) 2019; 1 e_1_2_11_32_1 e_1_2_11_31_1 e_1_2_11_30_1 e_1_2_11_36_1 e_1_2_11_14_1 e_1_2_11_35_1 e_1_2_11_12_1 e_1_2_11_34_1 e_1_2_11_11_1 e_1_2_11_33_1 e_1_2_11_29_1 e_1_2_11_28_1 Gündem NS (e_1_2_11_38_1) 2017; 48 e_1_2_11_5_1 e_1_2_11_27_1 e_1_2_11_4_1 e_1_2_11_26_1 e_1_2_11_3_1 e_1_2_11_2_1 Leung AK (e_1_2_11_7_1) 2018; 24 Moradi A (e_1_2_11_10_1) 2000; 2 Moghadam M (e_1_2_11_19_1) 2014; 43 e_1_2_11_21_1 e_1_2_11_44_1 e_1_2_11_20_1 e_1_2_11_45_1 Nokhodian Z (e_1_2_11_16_1) 2022; 51 Tabatabaei SR (e_1_2_11_15_1) 2013; 16 e_1_2_11_25_1 e_1_2_11_40_1 e_1_2_11_24_1 e_1_2_11_41_1 e_1_2_11_9_1 e_1_2_11_23_1 e_1_2_11_42_1 e_1_2_11_8_1 e_1_2_11_22_1 e_1_2_11_43_1 e_1_2_11_18_1 e_1_2_11_17_1 e_1_2_11_37_1 e_1_2_11_39_1  | 
    
| References_xml | – volume: 86 start-page: 197 issue: 3 year: 2008 end-page: 204 article-title: Towards elimination: measles susceptibility in Australia and 17 European countries publication-title: Bull World Health Organ – volume: 108 start-page: 524 year: 2021 end-page: 530 article-title: Seroprevalence of measles and rubella antibodies in vaccinated and unvaccinated infants in the Lao People's Democratic Republic publication-title: Int J Infect Dis – volume: 13 start-page: 52 year: 2022 article-title: Measles elimination successful and its relevant challenges in Iran publication-title: Int J Prev Med – volume: 36 start-page: 7909 issue: 52 year: 2018 end-page: 7912 article-title: Sero‐prevalence of rubella among pregnant women in India, 2017 publication-title: Vaccine – volume: 36 start-page: 424 issue: 6 year: 2023 end-page: 428 article-title: Investigation of the seroprevalence of antimeasles immunoglobulin G antibody in students at Shiraz University of Medical Sciences publication-title: Viral Immunol – volume: 37 start-page: 28 issue: 1 year: 2018 end-page: 34 article-title: Prevalence of rubella antibodies among children in the Democratic Republic of the Congo publication-title: Pediatr Infect Dis J – volume: 38 start-page: 1780 issue: 12 year: 2004 end-page: 1783 article-title: Development of a rubella vaccination strategy: contribution of a rubella susceptibility study of women of childbearing age in Kyrgyzstan, 2001 publication-title: Clin Infect Dis – volume: 204 start-page: S305 issue: Suppl_1 year: 2011 end-page: S311 article-title: Successful control and impending elimination of measles in the Islamic Republic of Iran publication-title: J Infect Dis – year: 2003 – volume: 17 start-page: 109 issue: 1 year: 2020 article-title: Seroprevalence of anti‐hepatitis E antibodies and antigens among HIV‐infected patients in Fars Province, southern Iran publication-title: Virol J – volume: 28 start-page: 121 issue: 2 year: 2022 end-page: 129 article-title: Immunization coverage of children aged 24‐35 months in the Islamic Republic of Iran: a national cluster coverage survey publication-title: East Mediterr Health J – volume: 16 start-page: 38 issue: 1 year: 2013 end-page: 41 article-title: Detection of serum antibodies against measles, mumps and rubella after primary measles, mumps and rubella (MMR) vaccination in children publication-title: Arch Iran Med – volume: 204 start-page: S664 issue: Suppl 2 year: 2011 end-page: S668 article-title: Serologic status of women in an urban population in Brazil before and after rubella immunization campaign using routine screening data publication-title: J Infect Dis – volume: 42 start-page: 239 issue: 3 year: 1999 end-page: 242 article-title: Rubella immune status among healthcare workers in the Department of Obstetrics and Gynaecology of a regional hospital in Hong Kong: the need for a vaccination policy publication-title: J Hosp Infect – volume: 15 start-page: 2851 issue: 12 year: 2019 end-page: 2853 article-title: Measles in pregnancy: a threat for Italian women? publication-title: Hum Vaccin Immunother – volume: 2 start-page: 253 issue: 4 year: 2002 end-page: 258 article-title: TORCH infections. Toxoplasmosis, other (syphilis, varicella‐zoster, parvovirus B19), rubella, cytomegalovirus (CMV), and herpes infections publication-title: Curr Womens Health Rep – volume: 30 start-page: 675 issue: 9 year: 2017 end-page: 677 article-title: Rubella seropositivity in pregnant women after vaccination campaign in Brazil's Federal District publication-title: Viral Immunol – volume: 17 start-page: 146 issue: 1 year: 2017 article-title: Rubella in Sub‐Saharan Africa and sensorineural hearing loss: a case control study publication-title: BMC Public Health – volume: 23 start-page: 1 issue: 1 year: 2022 end-page: 7 article-title: Seroconversion rates following 2 doses of measles‐mumps‐rubella vaccination given at the ages 12 and 18 months: data for possible additional dose at older age publication-title: BMC Immunol – volume: 2 start-page: 19 issue: 1 year: 2000 end-page: 25 article-title: Immune states against rubella virus among high‐school girl pupils in Gorgan publication-title: J Gorgan Univ Med Sci – volume: 41 start-page: 209 issue: 3 year: 2012 end-page: 218 article-title: Measles in pregnancy: a review publication-title: J Gynecol Obstet Biol Reprod – volume: 20 issue: 1 year: 2020 article-title: Measles outbreak in a rural population in Bahar District, Hamadan Province, West of Iran in 2018 publication-title: J Res Health Sci – volume: 15 start-page: 2117 issue: 9 year: 2019 end-page: 2120 article-title: Sero‐epidemiological evaluation of rubella immunity among pre‐marriage women in Iran publication-title: Hum Vaccin Immunother – volume: 8 issue: 1 year: 2013 article-title: Seroprevalence of anti‐rubella and anti‐measles IgG antibodies in pregnant women in Shiraz, southern Iran: outcomes of a nationwide measles‐rubella mass vaccination campaign publication-title: PLoS One – volume: 64 start-page: 189 issue: 1 year: 2019 end-page: 195 article-title: Immunosuppression does not affect antibody concentrations to measles, mumps, and rubella in patients with inflammatory bowel disease publication-title: Dig Dis Sci – volume: 21 start-page: 305 issue: 1 year: 2021 article-title: Measles and rubella serosusceptibity among population vaccinated with different schedules: the potential impact on measles‐rubella elimination in Iran publication-title: BMC Infect Dis – volume: 1 issue: 1 year: 2019 article-title: Systemic or chronic low‐grade inflammation in clinical conditions publication-title: J Injury Inflamm – volume: 20 start-page: O501 issue: 8 year: 2014 end-page: O504 article-title: Determinants of measles seroprevalence among pregnant women in Paris, France publication-title: Clin Microbiol Infect – volume: 51 start-page: 409 issue: 2 year: 2022 end-page: 415 article-title: A Nationwide study on the seroprevalence of measles, mumps, and rubella in Iranian children and adolescents publication-title: Iran J Public Health – volume: 12 start-page: 43 issue: 1 year: 2008 end-page: 46 article-title: Efficacy of measles and rubella vaccination one year after the nationwide campaign in Shiraz, Iran publication-title: Int J Infect Dis – volume: 21 start-page: 4435 issue: 12 year: 2020 article-title: Molecular epidemiology of B3 and D8 measles viruses through hemagglutinin phylogenetic history publication-title: Int J Mol Sci – volume: 14 start-page: 1412 issue: 6 year: 2018 end-page: 1416 article-title: Seroprevalence of antibodies to measles and rubella eight months after a vaccination campaign in the southeast of Iran publication-title: Hum Vaccin Immunother – volume: 43 start-page: 375 issue: 3 year: 2014 end-page: 380 article-title: Measles outbreak in south of Iran, where vaccine coverage was high: a case‐series study publication-title: Iran J Public Health – volume: 48 start-page: 65 issue: 1 year: 2017 end-page: 72 article-title: Seroprevalence of rubella antibodies among Turkish and foreign women in Turkey publication-title: Southeast Asian J Trop Med Public Health – volume: 22 start-page: 282 issue: 4 year: 2014 end-page: 286 article-title: Seroprevalence of rubella antibodies among adult Egyptian females aged 20‐30 years. Is there a need for rubella vaccination? publication-title: Cent Eur J Public Health – volume: 57 start-page: 347 issue: 5 year: 2011 end-page: 351 article-title: Measles–mumps–rubella revaccination; 18 months vs. 4–6 years of age: potential impacts of schedule changes publication-title: J Trop Pediatr – volume: 10 issue: 1 year: 2020 article-title: Recent trends in seroprevalence of rubella in Korean women of childbearing age: a cross‐sectional study publication-title: BMJ Open – volume: 41 start-page: 378 issue: 4 year: 2013 end-page: 380 article-title: Serological survey of mumps immunity among health care workers in the Catalonia region of Spain publication-title: Am J Infect Control – volume: 24 start-page: 512 issue: 5 year: 2018 end-page: 520 article-title: Measles: a disease often forgotten but not gone publication-title: Hong Kong Med J – volume: 35 start-page: 3076 issue: 23 year: 2017 end-page: 3081 article-title: Rubella virus immunization status in preconception period among Chinese women of reproductive age: a nation‐wide, cross‐sectional study publication-title: Vaccine – volume: 10 start-page: 468 issue: 4–5 year: 2004 end-page: 473 article-title: Prevalence of measles antibody in children of different ages in Shiraz, Islamic Republic of Iran publication-title: East Mediterr Health J – volume: 38 start-page: 235 issue: 2 year: 2020 end-page: 241 article-title: Seroprevalence of anti‐rubella and anti‐measles antibodies in women at the verge of marriage in Iran publication-title: Vaccine – ident: e_1_2_11_29_1 doi: 10.1186/s12985-020-01384-0 – volume: 16 start-page: 38 issue: 1 year: 2013 ident: e_1_2_11_15_1 article-title: Detection of serum antibodies against measles, mumps and rubella after primary measles, mumps and rubella (MMR) vaccination in children publication-title: Arch Iran Med – ident: e_1_2_11_34_1 doi: 10.1136/bmjopen-2019-030873 – ident: e_1_2_11_17_1 doi: 10.26719/emhj.21.059 – ident: e_1_2_11_14_1 doi: 10.1093/tropej/fmq102 – ident: e_1_2_11_42_1 doi: 10.2471/BLT.07.041129 – ident: e_1_2_11_18_1 doi: 10.1080/21645515.2018.1436920 – ident: e_1_2_11_36_1 doi: 10.1089/vim.2017.0012 – ident: e_1_2_11_30_1 doi: 10.1080/21645515.2018.1504527 – ident: e_1_2_11_2_1 doi: 10.1371/journal.pone.0055043 – ident: e_1_2_11_3_1 doi: 10.3390/ijms21124435 – ident: e_1_2_11_9_1 doi: 10.1093/infdis/jir076 – ident: e_1_2_11_20_1 doi: 10.1016/j.vaccine.2019.10.026 – ident: e_1_2_11_28_1 doi: 10.1016/j.ijid.2021.06.016 – volume: 2 start-page: 19 issue: 1 year: 2000 ident: e_1_2_11_10_1 article-title: Immune states against rubella virus among high‐school girl pupils in Gorgan publication-title: J Gorgan Univ Med Sci – ident: e_1_2_11_21_1 doi: 10.1186/s12879-021-05970-7 – ident: e_1_2_11_25_1 doi: 10.1016/j.ajic.2012.04.327 – volume: 24 start-page: 512 issue: 5 year: 2018 ident: e_1_2_11_7_1 article-title: Measles: a disease often forgotten but not gone publication-title: Hong Kong Med J – ident: e_1_2_11_23_1 doi: 10.1093/infdis/jir356 – ident: e_1_2_11_12_1 – ident: e_1_2_11_24_1 doi: 10.1186/s12865-021-00465-1 – ident: e_1_2_11_4_1 doi: 10.1016/j.jgyn.2012.01.008 – ident: e_1_2_11_27_1 – ident: e_1_2_11_11_1 doi: 10.26719/2004.10.4-5.468 – ident: e_1_2_11_41_1 doi: 10.1053/jhin.1999.0568 – volume: 48 start-page: 65 issue: 1 year: 2017 ident: e_1_2_11_38_1 article-title: Seroprevalence of rubella antibodies among Turkish and foreign women in Turkey publication-title: Southeast Asian J Trop Med Public Health – ident: e_1_2_11_39_1 doi: 10.1016/j.vaccine.2017.04.044 – ident: e_1_2_11_5_1 doi: 10.1186/s12889-017-4077-2 – volume: 1 issue: 1 year: 2019 ident: e_1_2_11_13_1 article-title: Systemic or chronic low‐grade inflammation in clinical conditions publication-title: J Injury Inflamm – volume: 43 start-page: 375 issue: 3 year: 2014 ident: e_1_2_11_19_1 article-title: Measles outbreak in south of Iran, where vaccine coverage was high: a case‐series study publication-title: Iran J Public Health – volume: 2 start-page: 253 issue: 4 year: 2002 ident: e_1_2_11_6_1 article-title: TORCH infections. Toxoplasmosis, other (syphilis, varicella‐zoster, parvovirus B19), rubella, cytomegalovirus (CMV), and herpes infections publication-title: Curr Womens Health Rep – ident: e_1_2_11_45_1 doi: 10.1007/s10620-018-5321-z – ident: e_1_2_11_44_1 doi: 10.1111/1469-0691.12469 – ident: e_1_2_11_43_1 doi: 10.1080/21645515.2019.1621146 – ident: e_1_2_11_26_1 – ident: e_1_2_11_35_1 doi: 10.1016/j.vaccine.2018.11.013 – volume: 51 start-page: 409 issue: 2 year: 2022 ident: e_1_2_11_16_1 article-title: A Nationwide study on the seroprevalence of measles, mumps, and rubella in Iranian children and adolescents publication-title: Iran J Public Health – ident: e_1_2_11_33_1 doi: 10.4103/ijpvm.IJPVM_334_20 – ident: e_1_2_11_32_1 doi: 10.1089/vim.2023.0026 – ident: e_1_2_11_8_1 doi: 10.1097/INF.0000000000001703 – ident: e_1_2_11_22_1 doi: 10.1016/j.ijid.2007.03.013 – ident: e_1_2_11_37_1 doi: 10.1086/421018 – ident: e_1_2_11_31_1 doi: 10.34172/jrhs.2020.05 – ident: e_1_2_11_40_1 doi: 10.21101/cejph.a4010  | 
    
| SSID | ssj0001723026 ssib044744397 ssib042166854  | 
    
| Score | 2.2510521 | 
    
| Snippet | Background
Rubella and measles are two highly contagious viral childhood diseases. However, the high possibility of brutal effects of both microorganisms... Rubella and measles are two highly contagious viral childhood diseases. However, the high possibility of brutal effects of both microorganisms during pregnancy... BackgroundRubella and measles are two highly contagious viral childhood diseases. However, the high possibility of brutal effects of both microorganisms during... Abstract Background Rubella and measles are two highly contagious viral childhood diseases. However, the high possibility of brutal effects of both...  | 
    
| SourceID | doaj unpaywall pubmedcentral proquest pubmed crossref wiley  | 
    
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher  | 
    
| StartPage | 95 | 
    
| SubjectTerms | Antibodies antibody Congenital diseases Disease Females Fetuses Health care policy immunization programs Laboratories Measles Miscarriage Mumps Original Pregnancy Rubella Sample size Serology Steroids vaccination Vaccines Viral infections Viruses Womens health  | 
    
| SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1tb9MwELZGJwFfEK8jMJBBiE-EJY5rJ0gIbWjdVmkVQkzat8hv6YrapLQLqP-JH8mdk7SqgH2MnbSO73z3XHx-jpA3rAA1sX0Rupj3Q24gYM1coUIFgZiBsBmcIu7ono_E6QUfXvYvd8ioOwuDaZWdTfSG2lYGv5EfsAywNJ5tY5_mP0KsGoW7q10JDdWWVrAfPcXYLbLLkBmrR3aPjkdfvnYaxlksRLpxoJxLjh5581VGAiT3NdrA9fm8ENkx1kbs4Pu4YO-FlFs-zFP9_wuf_p1meacu52r1S02n21DY-7LBfXKvBaH0sNGaB2THlQ_J7fN2m_0R-Q0WpFrWi59uRauCwuRPwkWNWxQKLmzTMHNqOXVLejY-8Q26woREOinpCi0ILdxMTZuGobpaVLN3dFn5fPqSIj8DPQM3ib0ADtgHekibUzT4h9M11zNewSMUFkpnpWlbZhwfxZ94TC4Gx98-n4ZtWYfQ9GE-Q6ajWHMIpFIhuQU4woQ0sYqZUTqRkRHWppFJZZa6whirHCBMxzJpUp3EQvHkCemVVemeEqrBIFmdGBVBu9FZqtGgFGCYCmmzlAfkVSeofN6wd-QNTzPLUZg5CDMgRyjBdT_ybfuGajHO2-WbJ4UAKCuEktpylZk04omKDBLCRX3lXED2O_nnrRFY5huVhXGsu2H54p6MKl1V-3sgYoWYLQnIXqMu65EkWOoAEF5A0i1F2hrqdk85ufIU4XGUMbC8IiCv1zp3wwy89cr43xvy4ckAhCSf3fyWz8ldBjPSZOjtk971onYvALJd65ftOvwDllw8mA priority: 102 providerName: ProQuest – databaseName: Unpaywall dbid: UNPAY link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELagKwEX3o_AggxCnEhJnMR2uBVEd7fSrjhQaTlFtuN0C21SNQ2onPgJ_BR-E7-EmbxEeQlxa-w4dexvxjOZ8WdCHrMMYJJG3LV-GLmhAYc1tplyFThiBtxmWBQxont8wg-n4eQ0Om0_uOFemIYfov_ghpJR62sU8FWaNXq-je6zZ-9mGRtyIc6TPR6BLT4ge9OT16O3eKKcL-u8DtH9BuDJjn32h6Y761FN2_87W_PXlMmLVb5S249qsdg1a-t1aXyFJN0bNeko74fVRg_Np5_IHv__la-Sy63JSkcNxq6Rcza_Ti4ct0H5G-Qr6JuirNYf7JYWGYWpmn_7_GVdYUhDwWXaFS2tKhe2pEezg7pIF5jCSOc53aLOoZldqkVTMFFn62L5lJZFnYGfU2R0oEewsGItmBPsOR3RZt8N_umiZ4fGK2hCQbQ6vU7bg8mxKT7iJpmOX715eei2B0G4JoIZdJn2fB2C6yW5CFMwYBgXxlc-M0oHwjM8TaVnpIilzYxJlQWb1LJYGKkDn6swuEUGeZHbO4RqUGGpDozyoNzoWGpUQRmoskyksQwd8rCDQ7Jq-D6ShtmZJTj0CQy9Q14gTvp6ZOiuC4r1LGkFPgkyDsYv50roNFSxkV4YKM8ghZwXKWsdst-hLGnVRpmwGBxG3MDJoB99NQg8RnFUbouqvgd8XPDyAofcbkDZ9yTAwxHAJnSI3IHrTld3a_L5WU0q7nsxA13NHfKoR_ZfRuBJjdM_3pBMDsYwSeLuvzztHrnEYFyazL59MtisK3sfTL2NftDK83f3FVXA priority: 102 providerName: Unpaywall – databaseName: Wiley Online Library Open Access dbid: 24P link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3LbtQwFLWgSNAN4lkCBRmEWBGaOIntsCuIaTtSEQsqdRfZjjMdNJNUSVM0Oz6BT-Gb-BLudR5VxEMsc20nlu87vj4m5CUrQEzyhPs2jBM_NpCwprZQvoJEzEDaDE4Rd3SPP_LDk3h-mpz2VZV4FqbDhxh_uKFmOHuNCq50s3cFGvplUbA3XIjr5EYIYQxKN4s_Xf1fERBcu9vWwImlPoidHLBnA7Y3DJ54Iwfa_6dI8_eCyVttea42X9VqNQ1qnVea3SG3-3CS7nf8v0uu2fIeuXncb5jfJz_AFlRNW1_aDa0KCsu4_Pnte93idoOCx3wgra1qVrahR4sDR9IVlhfSZUk3aA9oYddq1RHm6qyu1q9pU7nq-JIi2gI9AqeHreDq2Vu6T7szMfjR1YjcjE8whILYDzaX9peG41B8xQNyMvvw-f2h31_S4JskEcJnOgh1DGmR5CLOIbhgXJhQhcwoHYnA8DyXgZEilbYwJlcW4kXLUmGkjkKu4ugh2Sqr0j4iVIN5yXVkVAB0o1Op0TwUYGYKkacy9sjzgVnZeYfFkXWoyyxDhmbAUI-8Qy6O7Yie7QhVvch6ZcyigkNgyrkSOo9VamQQRyowCO8WJMpaj-wOMpD1Kt1kLIVkDg9XMpjH2AzKiDssqrRV6_pA_gkZWOSRnU5kxplEeHEBxGsekRNhmkx12lIuzxzgdxikDOwo98iLUe7-sQKvnED-tUM2P5gBk8Tj_-34hGwzWJuu8m6XbF3UrX0KodiFfuZ07heJHjHK priority: 102 providerName: Wiley-Blackwell  | 
    
| Title | Serosurvey of anti‐rubella and anti‐measles IgG antibodies in young females in Jahrom, southern west Iran in 2012: A review of literature of the serological profile in Iran | 
    
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjgf2.677 https://www.ncbi.nlm.nih.gov/pubmed/38481743 https://www.proquest.com/docview/2955095682 https://www.proquest.com/docview/2957165853 https://pubmed.ncbi.nlm.nih.gov/PMC10927936 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jgf2.677 https://doaj.org/article/3f665066a7bd4a9c8043a0c024805aee  | 
    
| UnpaywallVersion | publishedVersion | 
    
| Volume | 25 | 
    
| hasFullText | 1 | 
    
| inHoldings | 1 | 
    
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2189-7948 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001723026 issn: 2189-7948 databaseCode: KQ8 dateStart: 20150101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2189-7948 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001723026 issn: 2189-7948 databaseCode: DOA dateStart: 20150101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2189-7948 dateEnd: 99991231 omitProxy: true ssIdentifier: ssib044744397 issn: 2189-6577 databaseCode: M~E dateStart: 20150101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 2189-7948 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001723026 issn: 2189-7948 databaseCode: RPM dateStart: 20170101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2189-7948 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001723026 issn: 2189-7948 databaseCode: 7X7 dateStart: 20170101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 2189-7948 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001723026 issn: 2189-7948 databaseCode: BENPR dateStart: 20170101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVWIB databaseName: KBPluse Wiley Online Library: Open Access customDbUrl: eissn: 2189-7948 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001723026 issn: 2189-7948 databaseCode: AVUZU dateStart: 20150901 isFulltext: true titleUrlDefault: https://www.kbplus.ac.uk/kbplus7/publicExport/pkg/559 providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Open Access customDbUrl: eissn: 2189-7948 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001723026 issn: 2189-7948 databaseCode: 24P dateStart: 20150101 isFulltext: true titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html providerName: Wiley-Blackwell  | 
    
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LjtMwFLVgkIAN4k1gqAxCrAjjOI6dsOugdmYqtaoQlcoqsh1npihNRs0E1A3iE_gUvokv4TovTcVrwyaSr5PG8j2-j_rmGKEXNAWYJAF3jccCl2lIWCOTSldCIqYhbQanaHd0pzN-vGCTZbC8dNSXrQlr6IGbiTvwUw5BBOdSqITJSIeE-ZJoS8VFAmmMtb4kjC4lU_W_KwJCa8o7tllCDz6epvQ1F2LH_9Q0_b-LLX8tkbxR5edy-1lm2W4YW_uh8W10qw0g8bAZ-B10xeR30fVpu0V-D32H1V-U1eaT2eIixTBxqx9fv20qu8EgoZl0orWRZWZKfHJ6VItUYQsK8SrHW2sBcGrWMmsEE3m2KdavcFnU9fA5tvwK-ATcnO0F507f4CFuvoKxL816rmbbgkcwAL2zsrg9Jtw-an_iPlqMR-_fHrvtsQyuDgIhXKqIpxgkQiEXLIFwgnKhPelRLZUviOZJEhIdiig0qdaJNBAhGhoJHSrf45L5D9BeXuTmEcIKDEqifC0JyLWKQmUNQgqGJRVJFDIHPeuUFZ837Btxw7NMY6vQGBTqoEOrxb7f8mXXAkBR3KIo_heKHLTfYSBuF3EZ0wjSN_s5JYVx9N2w_OyeisxNUdX3QMYJOZfvoIcNZPqR-PaoAojQHBTugGlnqLs9-eqspvj2SETBcnIHPe9x95cZeFkD8o83xJOjMShJPP4fU_UE3aTQaOrw9tHexaYyTyEwu1ADdJWyOVzFUgzQtcPRbP5uUK9LuE6_jEC2mM2HH34CrnI-zw | 
    
| linkProvider | Directory of Open Access Journals | 
    
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELfGJjFeEP8JDDAIeCIscRw7QZrQBuvabp0Q2qS9BcdxuqI2Ke3K1O_EZ-CzceckrSpgb3uMnT9O7vy738XnO0JesxzUJAuFa3weulyDwxqbXLkKHDENbjMYRVzR7R2L9invnoVna-R3sxcGwyobTLRAnZUa_5Fvsxi4NO5tYx_HP1ysGoWrq00JDVWXVsh2bIqxemPHoZlfggs33el8Bnm_Yay1f_Kp7dZVBlwdhlK6LPX8lAOvj4TkGVhHJqT2lc-0SgPpaZFlkacjGUcm1zpTBgiPYbHUURr4QvEA7nuDbPCAx-D8beztH3_52mg0Z74Q0dJgcy45MoDlXyAJLoCtCQem1sahyCZDrse2v_dz9l5IuWIzbWmBf_Hhv8M6N2fFWM0v1XC4Sr2t7WzdIbdr0kt3Ky29S9ZMcY_c7NXL-vfJL0Cscjqb_DRzWuYUhD1wJzNcElFwkFUNI6OmQzOlnf6BbUhLDICkg4LOEbFobkZqWDV01fmkHL2j09LG7xcU80HQDphl7AUywj7QXVrt2sEHDhe5pfEILqEwMRurQOuy5ngp3uIBOb0WAT8k60VZmMeEpgCAWRpo5UG7TuMoRQDLAQhzmcURd8jLRlDJuMoWklR5oVmCwkxAmA7ZQwku-jG_t20oJ_2khoskyAVQZyGUTDOuYh15PFCexgR0XqiMcchWI_-kBp1pspwiMI5FN8AFrgGpwpQzew54yOAjBg55VKnLYiQBllYARumQaEWRVoa62lMMzm1Kct-LGSC9cMirhc5d8QXeWmX87wlJ96AFQpJPrn7LF2SzfdI7So46x4dPyS0GX6eKDtwi6xeTmXkGdPEifV7PSUq-XTcM_AHViHhs | 
    
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkQoXxJtAAYOAE2ETx7ETJIQKZdttacWBSnsLjuNsF-0my6ZLtf-JX8CvY8Z5rFZAbz3GzsPJjL_5Jh7PEPKC5aAmWShc4_PQ5Roc1tjkylXgiGlwm8Eo4oru0bHYP-EHw3C4QX63e2EwrLLFRAvUWanxH3mPxcClcW8b6-VNWMSX3f772Q8XK0jhSmtbTqNWkUOzPAf3rXo32AVZv2Ss_-nrx323qTDg6jCU0mWp56ccOH0kJM_AMjIhta98plUaSE-LLIs8Hck4MrnWmTJAdgyLpY7SwBeKB3DfK-SqDIIYwwnlsDPlnPlCRCtTzbnkaPtX_38kkH9bDQ6MrI1AkW1uXI_1vo9y9kZIuWYtbVGBfzHhvwM6ry2KmVqeq8lknXRbq9m_SW40dJfu1Pp5i2yY4jbZOmoW9O-QX4BVZbWY_zRLWuYUxDx25wtcDFFwkNUNU6OqianoYLRnG9ISQx_puKBLxCqam6ma1A0H6nReTl_TqrSR-wXFTBB0AAYZe4GGsLd0h9b7dfCBky6rNB7BJRSmZGsPaFPQHC_FW9wlJ5ci3ntksygL84DQFKAvSwOtPGjXaRylCF05QGAuszjiDnnWCiqZ1XlCkjojNEtQmAkI0yEfUIJdP2b2tg3lfJQ0QJEEuQDSLISSacZVrCOPB8rTmHrOC5UxDtlu5Z80cFMlq8kB4-i6AShw9UcVplzYc8A3Bu8wcMj9Wl26kQRYVAG4pEOiNUVaG-p6TzE-tcnIfS9mgPHCIc87nbvgC7yyyvjfE5KDvT4IST68-C2fki2Y_MnnwfHhI3KdwcepwwK3yebZfGEeA088S5_YCUnJt8tGgD92y3YG | 
    
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELagKwEX3o_AggxCnEhJnMR2uBVEd7fSrjhQaTlFtuN0C21SNQ2onPgJ_BR-E7-EmbxEeQlxa-w4dexvxjOZ8WdCHrMMYJJG3LV-GLmhAYc1tplyFThiBtxmWBQxont8wg-n4eQ0Om0_uOFemIYfov_ghpJR62sU8FWaNXq-je6zZ-9mGRtyIc6TPR6BLT4ge9OT16O3eKKcL-u8DtH9BuDJjn32h6Y761FN2_87W_PXlMmLVb5S249qsdg1a-t1aXyFJN0bNeko74fVRg_Np5_IHv__la-Sy63JSkcNxq6Rcza_Ti4ct0H5G-Qr6JuirNYf7JYWGYWpmn_7_GVdYUhDwWXaFS2tKhe2pEezg7pIF5jCSOc53aLOoZldqkVTMFFn62L5lJZFnYGfU2R0oEewsGItmBPsOR3RZt8N_umiZ4fGK2hCQbQ6vU7bg8mxKT7iJpmOX715eei2B0G4JoIZdJn2fB2C6yW5CFMwYBgXxlc-M0oHwjM8TaVnpIilzYxJlQWb1LJYGKkDn6swuEUGeZHbO4RqUGGpDozyoNzoWGpUQRmoskyksQwd8rCDQ7Jq-D6ShtmZJTj0CQy9Q14gTvp6ZOiuC4r1LGkFPgkyDsYv50roNFSxkV4YKM8ghZwXKWsdst-hLGnVRpmwGBxG3MDJoB99NQg8RnFUbouqvgd8XPDyAofcbkDZ9yTAwxHAJnSI3IHrTld3a_L5WU0q7nsxA13NHfKoR_ZfRuBJjdM_3pBMDsYwSeLuvzztHrnEYFyazL59MtisK3sfTL2NftDK83f3FVXA | 
    
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serosurvey+of+anti%E2%80%90rubella+and+anti%E2%80%90measles+IgG+antibodies+in+young+females+in+Jahrom%2C+southern+west+Iran+in+2012%3A+A+review+of+literature+of+the+serological+profile+in+Iran&rft.jtitle=Journal+of+general+and+family+medicine&rft.au=Najmeh+Mojarad&rft.au=Fatemeh+Forouzani&rft.au=Zahra+Mohammadi&rft.au=Reza+Shahriarirad&rft.date=2024-03-01&rft.pub=Wiley&rft.eissn=2189-7948&rft.volume=25&rft.issue=2&rft.spage=95&rft.epage=101&rft_id=info:doi/10.1002%2Fjgf2.677&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_3f665066a7bd4a9c8043a0c024805aee | 
    
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2189-7948&client=summon | 
    
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2189-7948&client=summon | 
    
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2189-7948&client=summon |